Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Marcello Lo Mele"'
Autor:
Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Matteo Fassan, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Vernaci, Ottavia Amato, Francesca Porra, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract Approximately a half of breast tumors classified as HER2-negative exhibit HER2-low-positive expression. We recently described a high instability of HER2-low-positive expression from primary breast cancer (BC) to relapse. Previous studies rep
Externí odkaz:
https://doaj.org/article/b2d164b6afd24d32a7d34c45e4f0a7df
Autor:
Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Matteo Fassan, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Vernaci, Ottavia Amato, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract About a half of HER2-negative breast cancer (BC) show HER2-low expression that can be targeted by new antibody-drug conjugates. The main aim of this study is to describe the evolution of HER2 expression from primary BC to relapse by includin
Externí odkaz:
https://doaj.org/article/474a667807c24ccf94e82782dbe6af54
Autor:
Francesco Garzotto, Rosanna Irene Comoretto, Silvia Michieletto, Gianpaolo Franzoso, Marcello Lo Mele, Dario Gregori, Maria Giuseppina Bonavina, Fernando Bozza, Francesca Caumo, Tania Saibene
Publikováno v:
Breast, Vol 58, Iss , Pp 93-105 (2021)
Pre-operative localization of non-palpable breast lesions with non-wired non-ionizing (NWNI) techniques may improve clinical outcomes as reoperation rate, cosmetic outcome and contribute to organizational aspects improvement in breast-conserving surg
Externí odkaz:
https://doaj.org/article/13cc0b3b212140a380c8ea4a3506562c
Autor:
Maria Vittoria Dieci, Gaia Griguolo, Michele Bottosso, Vassilena Tsvetkova, Carlo Alberto Giorgi, Grazia Vernaci, Silvia Michieletto, Silvia Angelini, Alberto Marchet, Giulia Tasca, Elisa Genovesi, Enrico Cumerlato, Marcello Lo Mele, PierFranco Conte, Valentina Guarneri
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-7 (2021)
Abstract Although 1% is the recommended cut-off to define estrogen receptor (ER) positivity, a 10% cut-off is often used in clinical practice for therapeutic purposes. We here evaluate clinical outcomes according to ER levels in a monoinstitutional c
Externí odkaz:
https://doaj.org/article/a5d10581508547cdb6d83e4a415f9496
Autor:
Loredana Urso, Grazia Vernaci, Jessica Carlet, Marcello Lo Mele, Matteo Fassan, Elisabetta Zulato, Giovanni Faggioni, Alice Menichetti, Elisabetta Di Liso, Gaia Griguolo, Cristina Falci, Pierfranco Conte, Stefano Indraccolo, Valentina Guarneri, Maria Vittoria Dieci
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Endocrine therapy represents the cornerstone of treatment in hormone receptor-positive (HR+), HER2-negative metastatic breast cancer (mBC). The natural course of this disease is marked by endocrine resistance, mainly due to Estrogen Receptor 1 (ESR1)
Externí odkaz:
https://doaj.org/article/28efcefbd228445b884d856109889621
Autor:
Maria Vittoria Dieci, Valentina Guarneri, Angelo Paolo Dei Tos, PierFranco Conte, Elisabetta Di Liso, Michele Bottosso, Marcello Lo Mele, Vassilena Tsvetkova, Federica Miglietta, Cristina Falci, Giovanni Faggioni, Giulia Tasca, Carlo Alberto Giorgi, Tommaso Giarratano, Eleonora Mioranza, Silvia Michieletto, Tania Saibene
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Background Phyllodes tumours (PTs) are rare fibroepithelial tumours accounting for 5 cm vs T≤2 cm). Higher tumour-infiltrating lymphocytes (TILs) were associated with borderline and malignant PT (p=0.023); TILs were not associated with phyllodes-re
Externí odkaz:
https://doaj.org/article/e3c7c72bd29746509cfeb4fa9974d264
Autor:
Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Matteo Fassan, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Vernaci, Ottavia Amato, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/5a209eb810624fa3b79e6ac0b52cc517
Autor:
Giovanni Zarrilli, Gianluca Businello, Maria Vittoria Dieci, Silvia Paccagnella, Valentina Carraro, Rocco Cappellesso, Federica Miglietta, Gaia Griguolo, Valentina Guarneri, Marcello Lo Mele, Matteo Fassan
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 21, p 8102 (2020)
Breast cancer evolves thanks to a dense and close interaction with the surrounding tumor microenvironment (TME). Fibroblasts, leukocytes, blood and lymphatic endothelial cells and extracellular matrix are the constituents of this entity, and they syn
Externí odkaz:
https://doaj.org/article/118d449d62084565bcf9b737ebbe7b25
Autor:
Pierfranco Conte, Antonio Rosato, Gian Luca De Salvo, Marcello Lo Mele, Giovanna Magni, Claudia Pinato, Francesca Schiavi, Loredana Urso, Tommaso Giarratano, Gaia Griguolo, Grazia Maria Vernaci, Gabriella Moretti, Simon Spazzapan, Antonino Musolino, Giancarlo Bisagni, Anna Tosi, Valentina Guarneri, Maria Vittoria Dieci
Purpose:The role of immunotherapy in hormone receptor (HR)-positive, HER2-negative breast cancer is underexplored.Patients and Methods:The neoadjuvant phase II GIADA trial (NCT04659551, EUDRACT 2016-004665-10) enrolled stage II–IIIA premenopausal p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::449a9fe461a52ff1aa0af6c33fa436d4
https://doi.org/10.1158/1078-0432.c.6531084
https://doi.org/10.1158/1078-0432.c.6531084
Autor:
Pierfranco Conte, Antonio Rosato, Gian Luca De Salvo, Marcello Lo Mele, Giovanna Magni, Claudia Pinato, Francesca Schiavi, Loredana Urso, Tommaso Giarratano, Gaia Griguolo, Grazia Maria Vernaci, Gabriella Moretti, Simon Spazzapan, Antonino Musolino, Giancarlo Bisagni, Anna Tosi, Valentina Guarneri, Maria Vittoria Dieci
Supplementary Data from Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::041c054cd55de64ba21e7acc9f066dda
https://doi.org/10.1158/1078-0432.22483143
https://doi.org/10.1158/1078-0432.22483143